Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

44.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

2.3K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
2.3K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

568
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
568

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Thliphthisasapphus</i> (Rubiaceae, Rubieae), a new species from Lefkada (Ionian Islands, Greece) and its ecological position.

PhytoKeys·2024
Same author

Nurse awareness of patients who may have incident delirium.

Nursing older people·2017
Same author

Dabigatran versus warfarin in patients with atrial fibrillation.

Nursing older people·2017
Same author

Use of probiotics for infection prevention in trauma patients.

Nursing older people·2017
Same author

Benefits of dark chocolate in treating metabolic syndrome.

Nursing older people·2016
Same author

Flexibility and choice improved residents' feeling of wellbeing.

Nursing older people·2016
Same journal

Pressure ulcer healing in hospitalised older adults: a scoping review.

Nursing older people·2026
Same journal

Supporting effective shared decision-making with people with dementia.

Nursing older people·2026
Same journal

How to develop nursing student practice placement opportunities in care homes.

Nursing older people·2026
Same journal

Building resilience through adversity: exploring the experiences of older migrant women.

Nursing older people·2026
Same journal

Recognition and management of hearing loss in older adults in care homes.

Nursing older people·2026
Same journal

Performative empathy in dementia care: ethics and practice.

Nursing older people·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.5K

Parkinson's disease awareness.

Ruth Sander1

  • 1University of Portsmouth.

Nursing Older People
|June 21, 2016
PubMed
Summary
This summary is machine-generated.

Parkinson's disease involves motor symptoms like tremor and rigidity, plus non-motor issues. Levodopa treatment becomes less effective over time, leading to movement complications.

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

26.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.5K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

26.4K

Area of Science:

  • Neurology
  • Neuroscience
  • Movement Disorders

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • Key motor symptoms include tremor, bradykinesia, rigidity, and postural instability.
  • Non-motor symptoms like depression, anxiety, cognitive decline, sleep issues, and fatigue are common.

Purpose of the Study:

  • To outline the primary clinical manifestations of Parkinson's disease.
  • To describe the typical progression of motor symptoms and treatment challenges.
  • To highlight the impact of long-term levodopa therapy on Parkinson's patients.

Main Methods:

  • Clinical observation and symptom analysis.
  • Review of patient treatment histories.
  • Assessment of therapeutic efficacy and side effects over time.

Main Results:

  • Levodopa provides initial symptom relief but efficacy diminishes within 5-7 years.
  • Long-term levodopa use is associated with 'on-off' phenomena and dyskinesia.
  • A comprehensive understanding of PD progression is crucial for patient management.

Conclusions:

  • Parkinson's disease presents with a complex array of motor and non-motor symptoms.
  • Managing Parkinson's disease requires adapting treatment strategies as the disease progresses.
  • Addressing both motor fluctuations and non-motor symptoms is essential for improving patient quality of life.